These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5981771)

  • 21. Natural history of progressive muscular dystrophy.
    Kobayashi A; Tokunaga J; Oshiro T; Iwamoto A
    Nihon Seikeigeka Gakkai Zasshi; 1969 Apr; 43(4):323-34. PubMed ID: 5816664
    [No Abstract]   [Full Text] [Related]  

  • 22. [Modifications of serum creatine phosphokinase activity under the influence of lithium gluconate in Duchenne's myopathy].
    Chazot G; Fournis Y; Robert JM; Aimard G; Devic M
    Lyon Med; 1972 Nov; 228(17):421-5. PubMed ID: 4658522
    [No Abstract]   [Full Text] [Related]  

  • 23. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy].
    Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C
    Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possible limitation or direct inhibition of pathological creatinuria in progressive muscular dystrophy by the use of large doses of anabolic steroids].
    DE TONI G
    Boll Soc Ital Biol Sper; 1959 Feb; 35(3):110-4. PubMed ID: 13638410
    [No Abstract]   [Full Text] [Related]  

  • 25. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme changes following prednisone-induced remission in progressive muscular dystrophy.
    Burckhardt D; LaDue JS
    N Y State J Med; 1967 Feb; 67(4):598-9. PubMed ID: 5232108
    [No Abstract]   [Full Text] [Related]  

  • 27. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 28. A "liver test" is not a liver test. Measuring serum creatine kinase can identify muscular dystrophy and avoid liver biopsy.
    Tim RW; Gaskell P; Stajich J
    N C Med J; 1998; 59(4):238-41. PubMed ID: 9682593
    [No Abstract]   [Full Text] [Related]  

  • 29. [Our experience in the treatment of progressive muscular dystrophy].
    Buscaino GA
    Acta Neurol (Napoli); 1966; 21(2):133-50. PubMed ID: 5961587
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine].
    Radu H; Stenzel K; Migea S; Bordeianu L
    Munch Med Wochenschr; 1967 Dec; 109(51):2702-5. PubMed ID: 4873261
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the treatment of progressive muscle dystrophy with an anabolic steroid].
    Ernst K
    Z Arztl Fortbild (Jena); 1966 Apr; 60(7):389-90. PubMed ID: 5983564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Study of muscular dystrophy. 2. Enzyme activities].
    Imai H; Yamagi K; Asano T; Niwa S; Kato Y
    Iryo; 1967 Jul; 21(7):854-8. PubMed ID: 5582481
    [No Abstract]   [Full Text] [Related]  

  • 33. Slowly progressive X-linked recessive muscular dystrophy (type 3b). Report of cases and review of the literature.
    Zellweger H; Hanson JW
    Arch Intern Med; 1967 Nov; 120(5):525-35. PubMed ID: 6054585
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience with and considerations on therapy of progressive muscular dystrophies].
    Beckmann R
    Hippokrates; 1968 Dec; 39(23):876-88. PubMed ID: 5718770
    [No Abstract]   [Full Text] [Related]  

  • 35. [A clinical trial of creatine monohydrate in muscular dystrophy patients].
    Matsumura T; Yokoe M; Nakamori M; Hattori N; Saito T; Nozaki S; Fujimura H; Shinno S
    Rinsho Shinkeigaku; 2004 Oct; 44(10):661-6. PubMed ID: 15568480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on progressive muscular dystrophy. II. Relation between clinical effect of adenosinetriphosphate on progressive muscular dystrophy and phosphate compounds in the muscle.
    Nakahara M
    Arzneimittelforschung; 1965 Jul; 15(7):782-5. PubMed ID: 5898681
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic possibilities in myopathies, specifically in progressive muscular dystrophy].
    Beckmann R
    Arch Kinderheilkd; 1965 Nov; 173(2):109-34. PubMed ID: 5329080
    [No Abstract]   [Full Text] [Related]  

  • 38. [Early and late results of treatment with anabolic steroids of progressive muscular dystrophy].
    Zwoździak W; Zgorzalewicz B
    Neurol Neurochir Pol; 1967; 1(3):345-51. PubMed ID: 6055670
    [No Abstract]   [Full Text] [Related]  

  • 39. [Allopurinol in progressive muscular dystrophy (author's transl)].
    Castro-Gago M; Jiménez JF; Torres-Colomer M; Fuster M; Paz M; Novo I; Peña J
    An Esp Pediatr; 1980 Oct; 13(10):865-76. PubMed ID: 7469188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long term observations in muscular dystrophy. Therapeutic influence of disease course in progressive muscular dystrophy (8 long term observations)].
    Schlenska GK; Kleine TO
    Med Welt; 1980 Jun; 31(25):940-4. PubMed ID: 6775171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.